search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8<sup>+</sup> T cells.

Eliza Mari Kwesi-Maliepaard ,
Muhammad Assad Aslam ,
Mir Farshid Alemdehy ,
Teun van den Brand ,
Chelsea McLean ,
Hanneke Vlaming ,
Tibor van Welsem ,
Tessy Korthout ,
Cesare Lancini ,
Sjoerd Hendriks ,
Tomasz Ahrends ,
Dieke van Dinther ,
Joke M M den Haan ,
Jannie Borst ,
Elzo de Wit ,
Fred van Leeuwen ,
Heinz Jacobs

Abstract

Cytotoxic T cell differentiation is guided by epigenome adaptations, but how epigenetic mechanisms control lymphocyte development has not been well defined. Here we show that the histone methyltransferase DOT1L, which marks the nucleosome core on active genes, safeguards normal differentiation of CD8+ T cells. T cell-specific ablation of Dot1L resulted in loss of naïve CD8+ T cells and premature differentiation toward a memory-like state, independent of antigen exposure and in a cell-intrinsic manner. Mechanistically, DOT1L controlled CD8+ T cell differentiation by ensuring normal T cell receptor density and signaling. DOT1L also maintained epigenetic identity, in part by indirectly supporting the repression of developmentally regulated genes. Finally, deletion of Dot1L in T cells resulted in an impaired immune response. Through our study, DOT1L is emerging as a central player in physiology of CD8+ T cells, acting as a barrier to prevent premature differentiation and controlling epigenetic integrity.

More about this publication

Proceedings of the National Academy of Sciences of the United States of America

Volume 117
Issue nr. 34
Pages 20706-20716
Publication date 25-08-2020

Full text links

Publisher website (DOI) 10.1073/pnas.1920372117
Europe PubMed Central 32764145
Pubmed 32764145

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.